Bristol-Myers Squibb

A change of the guard for the world’s biggest cancer companies
A change of the guard for the world’s biggest cancer companies
EP Vantage
cancer
Bristol-Myers Squibb
Celgene
M&A
Roche
AstraZeneca
Flag link:
Big Pharma giving more money to patient advocacy groups
Big Pharma giving more money to patient advocacy groups
Beckers Hospital Review
Big Pharma
JNJ
AbbVie
Bristol-Myers Squibb
Pfizer
Merck
AstraZeneca
patient advocacy groups
Flag link:
3 Drug Stocks Poised for Gains After Cancer Conference
3 Drug Stocks Poised for Gains After Cancer Conference
Investopedia
ESMO
cancer
Amgen
Incyte
Bristol-Myers Squibb
Flag link:
Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report
Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report
Fierce Pharma
Merck
Keytruda
Bristol-Myers Squibb
Pfizer
Eliquis
AbbVie
Humira
Flag link:
As Celgene becomes BMS, its I&I lead lands CEO job at Takeda spinoff
As Celgene becomes BMS, its I&I lead lands CEO job at Takeda spinoff
Fierce Biotech
Celgene
Bristol-Myers Squibb
M&A
Terrie Curran
Phathom
Flag link:
This Bristol-Partnered Biotech Stock Just Fumbled On A Cancer Study
This Bristol-Partnered Biotech Stock Just Fumbled On A Cancer Study
Investors Business Daily
Bristol-Myers Squibb
Nektar Therapeutics
breast cancer
clinical trials
NKTR-214
Flag link:
Mike Quigley has personal motivation leading oncology at Bristol-Myers Squibb
Mike Quigley has personal motivation leading oncology at Bristol-Myers Squibb
Bizjournals
Mike Quigley
oncology
Bristol-Myers Squibb
Opdivo
Yervoy
cancer immunotherapy
Flag link:
Bristol-Myers' (BMY) Opdivo Falls Flat in Brain Tumor Study
Bristol-Myers' (BMY) Opdivo Falls Flat in Brain Tumor Study
Yahoo/Zacks.com
Bristol-Myers Squibb
Opdivo
glioblastoma
Flag link:
[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
Motley Fool
FTC
Amgen
Celgene
Bristol-Myers Squibb
M&A
Otezla
Flag link:
Bristol-Myers CEO Giovanni Caforio Named PhRMA Board Chairman
Bristol-Myers CEO Giovanni Caforio Named PhRMA Board Chairman
Xtalks
PhRMA
Giovanni Caforio
Bristol-Myers Squibb
Pharma CEOs
Flag link:
With third pharma deal, IFM's unorthodox approach paying off
With third pharma deal, IFM's unorthodox approach paying off
Biopharma Dive
IFM Therapeutics
Novartis
Bristol-Myers Squibb
Flag link:
Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint
Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint
Endpoints
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
Flag link:
Bristol-Myers teams with BioMotiv to build and buy biotechs
Bristol-Myers teams with BioMotiv to build and buy biotechs
Fierce Biotech
Bristol-Myers Squibb
BioMotiv
M&A
biotech
Flag link:
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
Fierce Pharma
Pfizer
Bristol-Myers Squibb
Eliquis
Warfarin
bloodthinners
Europe
ESC
European Society of Cardiology
Flag link:
Bristol-Myers, AbbVie's multiple myeloma drug wins second EU nod as part of triple regimen
Bristol-Myers, AbbVie's multiple myeloma drug wins second EU nod as part of triple regimen
Endpoints
Bristol-Myers Squibb
AbbVie
Empliciti
Celgene
Europe
relapsed or refractory multiple myeloma
Flag link:
Six burning Otezla questions
Six burning Otezla questions
EP Vantage
Celgene
Otezla
Amgen
drug pricing
FTC
Tyk2
Bristol-Myers Squibb
Flag link:
Bristol-Myers opens up the Phase 0 pathway in testing its new cancer therapies, following in Celgene’s footsteps
Bristol-Myers opens up the Phase 0 pathway in testing its new cancer therapies, following in Celgene’s footsteps
Endpoints
Bristol-Myers Squibb
Celgene
Presage Biosciences
Phase 0 testing
drug development
Flag link:
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Stat
Amgen
Otezla
Celgene
M&A
Bristol-Myers Squibb
psoriasis
Flag link:
What happened a year ago this week in biopharma? August 12-18, 2018
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Flag link:
What happened a year ago this week in biopharma? August 12-18, 2018
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Flag link:

Pages